MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancerQiuyu Wang(Michigan Medicine), Qian Zhao(Shanghai East Hospital)Cell Death and DiseaseJuly 3, 201810.1038/s41419-018-0715-6Cited by 61SaveCiteExport RISWatch citationsRelated PapersIL11 signaling mediates piR-2158 suppression of cell stemness and angiogenesis in breast cancer|Theranostics|2023|37The hepatokine TSK maintains myofiber integrity and exercise endurance and contributes to muscle regeneration|JCI Insight|2022|7